Systematic Review Examining the Association Between Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Prescription and Abdominal Aortic …
K Tian, S Thanigaimani, K Gibson… - European Journal of …, 2024 - ejves.com
Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …
aortic aneurysms (AAAs) has not been established. This systematic review and meta …
Systematic review examining the association of angiotensin converting enzyme inhibitor and angiotensin receptor blocker prescription with abdominal aortic …
K Tian, S Thanigaimani, K Gibson… - European Journal of …, 2024 - Elsevier
Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …
aortic aneurysms (AAAs) has not been established. This systematic review and meta …
[HTML][HTML] Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair
K Salata, M Syed, MA Hussain, R Eikelboom… - Journal of vascular …, 2018 - Elsevier
Objective The objective of this study was to summarize the literature regarding the effects of
renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors …
renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors …
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study
KE Kristensen, C Torp-Pedersen… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …
Pharmacotherapy in clinical trials for abdominal aortic aneurysms: A systematic review and meta-analysis
Z Su, J Guo, Y Gu - Clinical and Applied Thrombosis …, 2022 - journals.sagepub.com
Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …
progression. This systematic review aimed to summarise available trial evidence on the …
Pathogenesis and management of abdominal aortic aneurysm
J Golledge, S Thanigaimani, JT Powell… - European Heart …, 2023 - academic.oup.com
Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …
[HTML][HTML] Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms
MJ Sweeting, SG Thompson, LC Brown… - Journal of vascular …, 2010 - Elsevier
OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …
or other classes of antihypertensive drug attenuate or increase growth rates of small …
Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin converting enzyme inhibitors and aortic rupture: population based case control study. Lancet. 2006; 368 …
A Daugherty, LA Cassis - Perspectives in vascular surgery …, 2007 - journals.sagepub.com
Background: Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and
rupture of aortic aneurysms in animals. We investigated the association between ACE …
rupture of aortic aneurysms in animals. We investigated the association between ACE …
[引用][C] Medical Treatment for Abdominal Aortic Aneurysms: No Good Evidence or No Good Trials?
KHF Wong, C Bicknell - European Journal of Vascular and Endovascular …, 2024 - Elsevier
In the treatment of abdominal aortic aneurysms (AAAs), medical management plays a major
role in reducing cardiovascular and peri-operative risk through blood pressure …
role in reducing cardiovascular and peri-operative risk through blood pressure …
Current theories and clinical trial evidence for limiting human abdominal aortic aneurysm growth
J Yu, S Liu, J Huang, W Wang - Current drug targets, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA) refers to localized dilation of abdominal
aorta. AAA is largely asymptomatic, but aneurysmal rupture results in a high mortality rate …
aorta. AAA is largely asymptomatic, but aneurysmal rupture results in a high mortality rate …